12 /100
LOW RISK
Score updated Jul 14, 2026

NUVL — Nuvalent, Inc. Dilution Risk Tracker

Track NUVL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NUVL — Get alerts when the score changes →

As of July 14, 2026, Nuvalent, Inc. (NUVL) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. Nuvalent, Inc. has a market capitalization of $8.72B, 3.13M shares outstanding, 266 institutional holders tracked. Key dilution vectors include approximately 74 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
22
💰 Cash Runway
0
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NUVL.
🔔 Track NUVL — Get forecast alerts →

💹 Market Data

Market Cap$8.72B
Shares Outstanding3.13M
FloatN/A
Cash$1.29B
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 10.4% shares (2026Q1 vs prior)
266 institutional holders · 89.64M shares
#1 DEERFIELD MANAGEMENT COMPANY, L.P. 17.25M shares
#2 FMR LLC 9.27M shares
#3 Paradigm Biocapital Advisors LP 5.32M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.91M
Days to Cover1.2
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Apr 13, 2026
4 INSIDER TRANSACTION Apr 08, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NUVL Shareholders

Nuvalent, Inc. (NUVL) has a DilutionScore of 12/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for NUVL shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NUVL in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NUVL alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NUVL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NUVL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NUVL
📊 NUVL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NUVL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.